HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the company received notice of issuance from the U.S. Patent and Trademark Office (USPTO) regarding U.S. Patent No. 9,138,328, which signifies Life Spine’s 100th patent to date.
The one hundred patents are global in nature and cover the range of Life Spine product lines. The latest patent issuance refers to a radially expandable interbody device and implantation tool, and describes the company’s LONGBOWTM Expandable Lateral Interbody System, the first interbody on the market that expands laterally in-situ, specifically for a direct lateral approach. With the LONGBOW interbody system, surgeons can minimize the need for retraction by as much as 45% compared to currently existing lateral implants, benefitting patients by reducing incision size and potential nerve damage associated with the lateral access approach.
“The issuance of this 100th patent marks a major milestone for Life Spine, which arrived more quickly than anticipated. Perhaps even more important than this particular patent’s issuance is that we have more than 140 additional pending patent applications. Many of these technologies will enable potentially faster recovery times and decreased post-operative pain for spine surgery patients,” said Rich Mueller, Chief Operating Officer at Life Spine.
About Life Spine
Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit http://www.lifespine.com.